Sterling Capital Management LLC Reduces Position in Masimo Corporation $MASI

Posted by Brenda Bartman on Jul 10th, 2026

Sterling Capital Management LLC decreased its holdings in shares of Masimo Corporation (NASDAQ:MASI – Free Report) by 97.0% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 322 shares of the medical equipment provider’s stock after selling 10,563 shares during the quarter. Sterling Capital Management LLC’s holdings in Masimo were worth $57,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Global Retirement Partners LLC purchased a new stake in Masimo in the fourth quarter worth $27,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of Masimo during the fourth quarter valued at $28,000. Los Angeles Capital Management LLC bought a new position in shares of Masimo in the fourth quarter worth about $31,000. Rothschild Investment LLC grew its holdings in shares of Masimo by 12,950.0% in the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after purchasing an additional 259 shares during the last quarter. Finally, Torren Management LLC purchased a new position in Masimo in the 4th quarter worth about $35,000. 85.96% of the stock is owned by institutional investors.

Masimo Stock Performance

Shares of NASDAQ:MASI opened at $179.95 on Friday. The company has a market capitalization of $9.42 billion, a PE ratio of -17.07, a P/E/G ratio of 1.82 and a beta of 1.11. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. Masimo Corporation has a 12-month low of $125.94 and a 12-month high of $179.99. The business’s fifty day simple moving average is $179.25 and its 200-day simple moving average is $165.98.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Raymond James Financial lowered shares of Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Wells Fargo & Company raised shares of Masimo to a “hold” rating in a research report on Wednesday, March 18th. Finally, Weiss Ratings raised shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Nine equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $180.40.

Get Our Latest Report on MASI

Masimo Profile

(Free Report)

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Sterling Capital Management LLC Reduces Position in Masimo Corporation $MASI

Masimo Stock Performance

Wall Street Analysts Forecast Growth

Masimo Profile

See Also

You might be interested in: